Notice type: 3rd Party Publications
Problem Or Issue:
Important Safety Information from AstraZeneca Pharmaceuticals (Ireland) DAC on Risk of medication errors with new pharmaceutical form of LYNPARZA (Olaparib)
Important Safety Information - LYNPARZA (Olaparib)